{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:53:35Z","timestamp":1791104015071,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ucl.2006.06.010","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T09:28:46Z","timestamp":1168421326000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Case for Bladder Botulinum Toxin Application"],"prefix":"10.1016","volume":"33","author":[{"given":"Dae Kyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ucl.2006.06.010_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.20003","article-title":"Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin","volume":"19","author":"Erbguth","year":"2004","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.010_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.010_bib3","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.010_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssyngeria in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.010_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005392-199907000-00002","article-title":"Intravesical capsaicin and resiniferatoxin: spicing up the ways to treat the overactive bladder","volume":"162","author":"Chancellor","year":"1999","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib6","first-page":"401","article-title":"Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures?","volume":"18","author":"Stohrer","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ucl.2006.06.010_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib8","first-page":"522","article-title":"Botulinum-A toxin in the treatment of detrusor hyperreflexia","volume":"20","author":"Del Popolo","year":"2001","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.ucl.2006.06.010_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Hyperhidrosis study group: botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ucl.2006.06.010_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/1097-0142(20001015)89:8<1659::AID-CNCR2>3.0.CO;2-M","article-title":"Frey syndrome: treatment with type A botulinum toxin","volume":"89","author":"Von Lindern","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib12","first-page":"521","article-title":"Botulinum toxin-A to treat detrusor hyperreflexia in spinal cord injured patients","volume":"20","author":"Schurch","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ucl.2006.06.010_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib14","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A for treating neurogenic detrusor overactivty combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ucl.2006.06.010_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum-A toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum A-toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.010_bib19","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"de Paiva","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.010_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"Development of resistance to botulinum toxin type A in patients with torticollis","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ucl.2006.06.010_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","article-title":"Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia","volume":"60","author":"Jankovic","year":"2003","journal-title":"Neurology"},{"issue":"Suppl 8","key":"10.1016\/j.ucl.2006.06.010_bib22","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/mds.20004","article-title":"Molecular targets of botulinum toxin at the mammalian neuromuscular junction","volume":"19","author":"Whelchel","year":"2004","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.010_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"issue":"4 Suppl","key":"10.1016\/j.ucl.2006.06.010_bib24","first-page":"373","article-title":"Outcome\u00a0of repeat detrusor injections of botulinum A toxin (BTX-A) for severe neurogenic detrusor overactivity and incontinence","volume":"169","author":"Grosse","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib26","first-page":"410","article-title":"Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by\u00a0botulinum toxin type A\u2014a pilot study","volume":"20","author":"Radziszewski","year":"2001","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.010_bib27","first-page":"412","article-title":"Trigonum\u00a0and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency-syndrome refractory to conservative medical treatment and electrical stimulation","volume":"20","author":"Zermann","year":"2001","journal-title":"Neurourol\u00a0Urodyn"},{"issue":"4 Suppl","key":"10.1016\/j.ucl.2006.06.010_bib28","first-page":"124","article-title":"Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence","volume":"169","author":"Loch","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single institution experience in 110 patients with botulinum toxin-A injection into the bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2006.06.010_bib30","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.010_bib31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.010_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.010_bib33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.010_bib35","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.010_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0702041","article-title":"Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats","volume":"125","author":"Somogyi","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ucl.2006.06.010_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjp.0703068","article-title":"Urothelium-derived inhibitory factor(s) influence detrusor muscle contractility in vitro","volume":"129","author":"Hawthorn","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ucl.2006.06.010_bib38","series-title":"Recent advances in cellular and molecular biology, vol. 3","first-page":"109","article-title":"Free terminal fibers of autonomic nerves in the mucosa of the cat urinary bladder","author":"Wakabayashi","year":"1991"},{"key":"10.1016\/j.ucl.2006.06.010_bib39","first-page":"523","article-title":"Acetylcholinesterase positive axons in the mucosa of urinary bladder of adult cats: retrograde tracing and degeneration studies","volume":"10","author":"Wakabayashi","year":"1995","journal-title":"Histol Histopathol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.010_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor\u2014which is the main mechanism of action?","volume":"43","author":"Andersson","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(03)00114-X","article-title":"Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions","volume":"61","author":"Smith","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ucl.2006.06.010_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-5347(05)65403-1","article-title":"P2X receptors and their role in female idiopathic detrusor instability","volume":"167","author":"O'Reilly","year":"2002","journal-title":"J Urol"},{"issue":"1\u20132","key":"10.1016\/j.ucl.2006.06.010_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.010_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib45","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.010_bib46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401430600070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401430600070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:19:11Z","timestamp":1758806351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401430600070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S009401430600070X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2006.06.010","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Case for Bladder Botulinum Toxin Application","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2006.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}